albendazole has been researched along with guaifenesin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Albrecht, H; Laufs, R; Schäfer, H; Schottelius, J; Schwartz, DA; Sobottka, I; Visvesvara, GS | 1 |
1 review(s) available for albendazole and guaifenesin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for albendazole and guaifenesin
Article | Year |
---|---|
Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Albendazole; Animals; Antiprotozoal Agents; Autopsy; Duodenum; Encephalitozoonosis; Feces; Fluorescent Antibody Technique, Indirect; Humans; Male; Mucus; Treatment Outcome; Urine | 1995 |